YD Bio (YDES) Stock Price, News & Analysis

Company Overview

YD Bio Limited is a biotechnology company focused on the development of DNA methylation-based cancer detection technologies and ophthalmologic innovations. The company also provides clinical trial support and related research services.

YD Bio Limited is headquartered in Taipei, Taiwan, and its ordinary shares trade on the Nasdaq Global Market under the ticker symbol YDES.

Key Stats

• Today's Range: $3.50 to $4.02
• 50-Day Range: $1.90 to $4.80
• 52-Week Range: $1.70 to $25.00
• Volume: 567,647 shs
• Average Volume: 88,808 shs
• Market Capitalization: $266.17 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Company Calendar

• Today: 9/02/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: NASDAQ:YDES
• CIK: 2011674
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: 2025

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 70,790,000
• Free Float: N/A
• Market Cap: $266.17 million
• Optionable: N/A
• Beta: N/A